journal article·2018-11-05Open access

Near-infrared light-activatable siRNA delivery by microcapsules for combined tumour therapy

Yalan Rui, Bo Pang, Jinnan Zhang, Yuxi Liu, Huixin Hu, Zicun Liu, Sarah Ama Baidoo, Chang Liu, Yu Zhao, Siwen Li

Abstract

A polyelectrolyte microcapsule-based layer-by-layer (LbL) technique has been widely used as a multifunctional vehicle for combined tumor therapy. Meanwhile, with the rapid development of combined tumour therapy, the challenge for designing multifunctional drug delivery system has attracted much more attention. Herein, we developed a new type of microcapsule (MC) system called MPA@siRNA@DOX@MC, which conjugated with siRNA and DOX as well as ICG-Der-02 (MPA) by electrostatic absorption. MPA as indocyanine green (ICG) fluorescence dye, exhibiting high fluorescence emission and photothermal conversion ability under NIR laser irradiation, was uploaded onto this drug system for realizing the controllable drug release and cancer theranostics. In addition, the results revealed that MPA@siRNA@DOX@MC possessed several ideal properties including high drug-loading capacity, excellent siRNA transfection efficiency, siRNA sequence protection and remarkably improved tumour-targeting capacity. Moreover, the combined therapy based on this drug system displayed improved therapeutic efficacy and negligible side effects both in vivo and in vitro experiment. Ultimately, MPA@siRNA@DOX@MC drug delivery system successfully combined the photothermal therapy and chemotherapy with controlled siRNA sequence silencing may have a promising potential in combined tumor therapy.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: RNA Interference and Gene Delivery · Nanoplatforms for cancer theranostics · Advanced biosensing and bioanalysis techniques

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Biomedical Engineering, State Key Laboratory of Natural Medicines, School of Engineering, China Pharmaceutical University, Nanjing, Jiangsu Province, People's Republic of China;

Traditional Chinese Medicine and Biotechnology Research and Development Center, Changchun University of Traditional Chinese Medicine, Changchun, Jilin, People's Republic of China;

Department of Neurosurgery, China–Japan Union Hospital, Jilin University, Changchun, Jilin, People's Republic of China

Funding

Natural Science Foundation Committee of China · Natural Science Foundation of Jiangsu Province

References (31)

Show source-provided references
1. 10.1039/c3cs60393h10.1039/c3cs60393h ↗
2. 10.1002/adma.20150266010.1002/adma.201502660 ↗
3. 10.1039/c2cs35088b10.1039/c2cs35088b ↗
4. 10.1002/adfm.20150438510.1002/adfm.201504385 ↗
5. 10.1007/s40005-014-0153-010.1007/s40005-014-0153-0 ↗
6. 10.1021/cm702254h10.1021/cm702254h ↗
7. 10.1016/j.addr.2013.12.00810.1016/j.addr.2013.12.008 ↗
8. 10.1021/acs.nanolett.7b0157110.1021/acs.nanolett.7b01571 ↗
9. 10.1002/adma.20170328510.1002/adma.201703285 ↗
10. 10.1080/21691401.2017.130721010.1080/21691401.2017.1307210 ↗
11. Mansoori B · Artif Cells Nanomed Biotechnol · 2015 · 13 · 1
12. 10.1021/ar300048p10.1021/ar300048p ↗
13. 10.1016/j.addr.2016.06.01110.1016/j.addr.2016.06.011 ↗
14. 10.1021/nn103044z10.1021/nn103044z ↗
15. 10.1016/j.addr.2011.03.00710.1016/j.addr.2011.03.007 ↗
16. 10.1021/acsnano.5b0814510.1021/acsnano.5b08145 ↗
17. 10.1002/adma.20170044810.1002/adma.201700448 ↗
18. 10.1002/adma.20130121710.1002/adma.201301217 ↗
19. 10.1002/adma.20170419610.1002/adma.201704196 ↗
20. 10.1021/am500439310.1021/am5004393 ↗
21. 10.1021/nn506238610.1021/nn5062386 ↗
22. 10.1016/j.jconrel.2017.05.01110.1016/j.jconrel.2017.05.011 ↗
23. 10.1021/nn400334y10.1021/nn400334y ↗
24. 10.1016/j.cis.2014.04.00110.1016/j.cis.2014.04.001 ↗
25. 10.1021/acs.molpharmaceut.7b0032010.1021/acs.molpharmaceut.7b00320 ↗
26. 10.1093/nar/gkx50710.1093/nar/gkx507 ↗
27. 10.3109/21691401.2014.90982110.3109/21691401.2014.909821 ↗
28. 10.7150/thno.1760210.7150/thno.17602 ↗
29. 10.1021/acsami.7b0619210.1021/acsami.7b06192 ↗
30. 10.1021/acsami.6b1126210.1021/acsami.6b11262 ↗
31. 10.1016/j.jconrel.2016.02.01710.1016/j.jconrel.2016.02.017 ↗